Articles Referencing MDCO
Pediatric Approval for MDCO/BMY's Recothrom - Analyst Blog
5/15/2013, 4:27 pm from Zacks.com in Investing, Business, Stocks
The Medicines Company ( MDCO ) recently gained
US Food and Drug Administration (FDA) approval for the use of
Recothrom in pediatric patients. The FDA expanded Recothrom's label
following... Read >>
Earnings Increase at The Medicines Co. - Analyst Blog
4/26/2013, 5:22 pm from Zacks.com in Investing, Business, Earnings, Stocks
The Medicines Company ( MDCO ) reported first
quarter earnings of 24 cents per share, compared with the year-ago
earnings of 14 cents per share. Including one-time items, the company... Read >>
MDCO's Cangrelor Impresses - Analyst Blog
3/11/2013, 6:28 pm from Zacks.com in Investing, Business, Stocks
The Medicines Company ( MDCO ) recently
presented full results on its phase III candidate, Cangrelor, from
the phase III double-blind, CHAMPION PHOENIX study. Cangrelor was
compared to oral... Read >>
Encouraging News for Cubist Pharma - Analyst Blog
3/1/2013, 5:00 pm from Zacks.com in Investing, Business, Stocks
Recently, Cubist Pharmaceuticals Inc. ( CBST ) received some
encouraging news when the US Food and Drug Administration (FDA)
designated its antibiotic candidate... Read >>
Waiting Out a Stock Correction
3/1/2013, 2:29 pm from Cabot Heritage Corporation in Investing, Stocks
Stock Market Video Waiting Out a Stock Correction The Stock that Cannot Sell Itself is Poor Indeed In Case You Missed It --- In this week's Stock Market Video, I point out that although... Read >>
Time, Money and Growth Investing
2/22/2013, 2:22 pm from Cabot Heritage Corporation in Investing, Stocks
Stock Market Video Time, Money and Growth Investing We are a Herd of Independent Mind In Case You Missed It --- In this week's Stock Market Video I talk about the market's
two-day swoon... Read >>
4Q Beat for The Medicines Co. - Analyst Blog
2/22/2013, 2:19 pm from Zacks.com in Investing, Business, Stocks
The Medicines Company ( MDCO ) reported fourth
quarter earnings of 71 cents per share, compared with the year-ago
earnings of 48 cents per share. The Zacks Consensus Estimate for
the fourth... Read >>
MDCO-BMY Deal Comes into Effect - Analyst Blog
2/11/2013, 2:45 pm from Zacks.com in Investing, Business, Stocks
The Medicines Company ( MDCO ) recently
announced that its two-year global collaboration agreement for
Recothrom with Bristol-Myers Squibb ( BMY ) has come into
force. The two companies... Read >>
Alnylam-MDCO Join for ALN-PCS - Analyst Blog
2/5/2013, 5:45 pm from Zacks.com in Investing, Business, Stocks
Alnylam Pharmaceuticals Inc. ( ALNY ) recently
entered into an exclusive global alliance with The
Medicines Company ( MDCO ) for the
development and commercialization of the prior's... Read >>
Weekly CFO Sells Highlight: BK, MDCO, EBAY, MS, PHMD
1/27/2013, 3:18 pm from GuruFocus in Investing
According to GuruFocus Insider Data , the largest CFO sells
during the past week were: Bank of New York Mellon Corp, Medicines,
eBay Inc, Morgan Stanley, and PhotoMedex Inc. Bank of New... Read >>
Weekly CFO Sells Highlight: MDCO, SIG, VCI, PHMD, SNPS
1/21/2013, 10:14 am from GuruFocus in Investing
According to GuruFocus Insider Data , the largest CFO sells
during the past week were: The Medicines Company, Signet Jewelers
Ltd., Valassis Communications Inc., PhotoMedex Inc. and
Synopsys.... Read >>
The Medicines Co. Acquires Incline - Analyst Blog
1/11/2013, 5:34 pm from Zacks.com in Investing, Business, Stocks
The Medicines Company ( MDCO ) recently
announced that it has completed its acquisition of Incline
Therapeutics, Inc., for an upfront fee of $185 million. In addition, The Medicines... Read >>
Positive Results on MDCO's Cangrelor - Analyst Blog
1/10/2013, 11:40 am from Zacks.com in Investing, Business, Stocks
The Medicines Company ( MDCO ) recently
received good news with the company announcing positive results on
its phase III candidate, cangrelor. Cangrelor is being developed
for the... Read >>
MDCO Scores in SOLO-1 Trial - Analyst Blog
12/24/2012, 11:40 am from Zacks.com in Investing, Business, Stocks
The Medicines Company ( MDCO )
recently received good news with the company announcing positive
results on its phase III antibiotic candidate, oritavancin.
Oritavancin was being evaluated... Read >>
An Investment Update On Trius Therapeutics' Tedizolid
8/22/2012, 10:34 am from SeekingAlpha in Investing, Stocks
By Smith On Stocks : Investment Recommendation I am reiterating my buy recommendation on Trius Therapeutics
(NASDAQ: [[TSRX]]). This note is follow-up to a 35 page report called... Read >>